Novogen Announces FDA Approves IND Application for Cantrixil in Ovarian Cancer
September 11, 2016 at 19:30 PM EDT
Novogen Ltd (NASDAQ: NVGN) today announced that it had received confirmation from the United States Food and Drug Administration (FDA) ...
